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2ABSTRACT
UDP-N-acetylglucosamine pyrophosphorylase (UAP1) catalyses the last step in eukaryotic biosynthesis of 
uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc), converting UTP and GlcNAc-1P to the sugar 
nucleotide. Gene disruption studies have shown that this gene is essential in eukaryotes and a possible antifungal 
target, yet no inhibitors of fungal UAP1 have so far been reported. Here we describe the crystal structures of 
substrate/product complexes of UAP1 from Aspergillus fumigatus that together provide snapshots of catalysis. A 
structure with UDP-GlcNAc, pyrophosphate and Mg2+ provides the first Michaelis complex trapped for this class 
of enzyme, revealing the structural basis of the previously reported Mg2+ dependence and direct observation of 
pyrophosphorolysis. We also show that a highly conserved lysine mimics the role of a second metal observed in 
structures of bacterial orthologues. A mechanism-inspired UTP α,β-methylenebisphosphonate analogue (meUTP) 
was designed and synthesized and was shown to be a micromolar inhibitor of the enzyme. The mechanistic 
insights and inhibitor described here will facilitate future studies towards the discovery of small molecule 
inhibitors of this currently unexploited potential antifungal drug target.
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3INTRODUCTION
Yeast and fungi are encapsulated by a cell wall that is important for morphogenesis and provides 
chemical/mechanical protection from the environment. Fungal cell walls are composed mainly of glucans, chitin 
and mannoproteins (1). Chitin is a (1,4)-linked homopolymer of N-acetylglucosamine residues, accounting for 
only 1 – 2 % of the cell mass in yeast (2, 3), whereas the cell wall of filamentous fungi contains higher amounts 
of chitin, up to 10 – 20 % of the dry weight (4). Chitin is synthesized from UDP-GlcNAc, which is also a sugar 
donor for the synthesis of glycoproteins, glycosaminoglycans and glycosylphosphatidylinositol (GPI) anchors in 
eukaryotes as well as molecules such as lipopolysaccharide in prokaryotes.  In eukaryotes, UDP-GlcNAc is 
synthesized from fructose-6-phosphate (Fru-6P) and L-glutamine by a cascade of four enzymatic reactions 
(Figure 1); (i) conversion of Fru-6P to GlcN-6P, (ii) acetylation of GlcN-6P to GlcNAc-6P, (iii) isomerization of 
GlcNAc-6P to GlcNAc-1P, and (iv) the uridylation of GlcNAc-1P to the sugar nucleotide UDP-GlcNAc. The 
enzymes involved in this pathway are (i) GlcN-6P synthase (GFA1), (ii) GlcN-6P acetyltransferase (GNA1), (iii) 
phosphoacetylglucosamine mutase (AGM1) and (iv) UDP-GlcNAc pyrophosphorylase (UAP1) (Figure 1), 
respectively  (5). Knock out studies of any of these genes have produced lethal phenotypes in a range of eukaryotes 
(6-8), with the exception of the knockout of GFA1, which produces GlcN/GlcNAc auxotrophic mutants (9), and 
the enzymes are considered to be potential drug targets. One species-specific allosteric inhibitor has been 
described for T. brucei UAP1(10), but no mechanism-based inhibitors have so far been reported for any of the 
last three enzymes in the pathway. 
UDP-GlcNAc pyrophosphorylase (E.C.2.7.7.23) is a member of the large family of nucleotide diphosphate sugar 
pyrophosphorylases (7). Eukaryotic UDP-GlcNAc pyrophosphorylase catalyzes the synthesis of UDP-GlcNAc 
from UTP and GlcNAc-1P and also the reverse pyrophosphorolysis of UDP-GlcNAc (UTP + GlcNAc-1P  
UDP-GlcNAc + PPi). Eukaryotic UAP1s have been categorized into mammalian UAP1 and non-mammalian 
UAP1 (11). The crystal structures of the two isoforms (AGX1 and AGX2) of human UAP1 (hUAP1) were the 
first UAP1 structures to be reported (12). UAP1s consist of an N-terminal domain, a central pyrophosphorylase 
domain and a C-terminal domain. The functions of the N and C-terminal domains are not yet known (11, 12). 
Non-mammalian UAP1s possess a primary structure similar to that of mammalian UAP1s, but lack an “insertion 
loop” of more than 10 amino acids residues (11) as visualised in the crystal structures of Candida albicans and 
Aspergillus fumigatus UAP1s (CaUAP1 and AfUAP1 respectively) (Figure S1) (11, 13). Together, these human 
and C. albicans UAP1 structures, solved in complex with substrates/products, suggest an SN2 reaction mechanism 
in which phosphate oxygen of GlcNAc-1P attacks the UTP -phosphate, forming UDP-GlcNAc and releasing 
inorganic pyrophosphate (PPi). Although it has been shown that divalent cations facilitate the reactions catalysed 
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4by UAP1, their mechanistic roles are not clear, and the available structures have been determined in the absence 
of any such ions.
   Aspergillus fumigatus is the major cause of Aspergillosis, an often invasive and potentially life-threatening 
infection, found most frequently in immunocompromised patients (14, 15). As a step towards chemically 
validating A. fumigatus UDP-N-acetylglucosamine pyrophosphorylase (AfUAP1) as a potential drug target, we 
report the crystal structure of AfUAP1 in complex with the two reaction products, UDP-GlcNAc and 
pyrophosphate, and the cofactor magnesium ion, representing the first Michaelis complex for this enzyme family. 
Together with additional substrate/product complexes of this enzyme, this provides a range of snapshots of the 
reaction mechanism, revealing key conformational changes and essential participation of the magnesium ion and 
Lys437 in catalysis. A mechanism-inspired ,-methylenebisphosphonate UTP analogue (meUTP) is the first 
example of a eukaryotic pyrophosphorylase inhibitor, providing a basis for the future design of small molecule 
inhibitor for this class of enzymes. 
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5EXPERIMENTAL
Recombinant AfUAP1 production and structure determination  
 AfUAP1 was expressed as described recently (13). The protein (20 mg/ml) was co-crystallized with UTP, 
GlcNAc-1P and UDP-GlcNAc respectively by incubating the protein with 5 mM of the ligands at 4 oC for 2 h 
before setting up crystal trays. Crystals grew after three days in a condition containing 0.2 M sodium formate and 
20 % PEG3350. To obtain the UAP1-UDP-GlcNAc–PPi-Mg2+ ion complex, an AfUAP1-UDP-GlcNAc crystal 
was soaked for 10 seconds in a cryo-protectant (mother liquor + 10 % glycerol) containing 10 mM pyrophosphate 
and 10 mM magnesium. Prior to data collection, crystals were cryo-protected in mother liquor containing 10 % 
glycerol. Data were collected at the European Synchrotron Radiation Facility (ESRF) (Grenoble, France) and 
processed with the HKL suite(16). The AfUAP1-UDP-GlcNAc structure and other complexes described here were 
solved by molecular replacement with MOLREP (17) using the PDB entry 4BMA as the template (13). This gave 
a solution with two molecules in the asymmetric unit. The resulting electron density map was of good quality, 
allowing WarpNtrace (18) to build a model containing most residues. REFMAC (19) was used for further 
refinement, iterated with model building using COOT (20), producing a final models with the statistics shown in 
Table 1. Models for ligands were not included until their conformations were fully defined by unbiased |Fo|- |Fc|, 
calc electron density maps. Ligand structures and topologies were generated by PRODRG(21). WHATIF (22) 
was used to calculate hydrogen bonds and PyMOL was used to generate figures (23).
Enzyme kinetics and inhibition 
AfUAP1 steady-state kinetics was studied under linear conditions with not more than 10 % of the substrate 
converted to products. The activity of the enzyme in the forward direction was determined as described previously 
(13). The enzymes were used at 20 nM with the exception of K148M mutant that was used at 185 nM. The 
absorbance intensity data were analyzed with nonlinear regression analysis using GRAFIT 5 (24) with the default 
equations for the first-order reaction rates and Michaelis-Menten steady-state kinetics. To investigate AfUAP1 
inhibition by meUTP the forward reaction (formation of UDP-GlcNAc) was assayed using high performance 
anion exchange chromatography (HPAEC) based assay. The reaction mixtures (20 µM UTP, 50 µM GlcNAc-1P, 
1 mM DTT, 5 nM enzyme, 50 mM Tris-HCl pH 8.0, 10 mM MgCl2 and 2 % glycerol, total volume 100 µl) with 
and without varying concentrations of the inhibitor (0–1000 µM) were incubated for 30 min and the reactions 
were terminated by the addition of 10 µl of 0.1 M NaOH (~10 mM final concentration)  prior to analysis on a 
CarboPac-PA-1 column (Dionex) equilibrated with a 80:20 mixture of 1 mM NaOH  and a 1:1 mixture of 1 mM 
NaOH and 1 M sodium acetate as described previously (25). The eluent was monitored at 260 nm and peaks were 
identified by comparison to standards. The IC50 was calculated using Graphpad Prism software, CA, USA 
(www.graphpad.com).
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6Synthesis of an ,-methylenebisphosphonate UTP (meUTP) 
Compound 2 (Scheme 1): To a hot (60 °C) solution of 2´, 3´-O-isopropylidene uridine 1 (0.668 g, 2 mmol), 
triphenylphosphine (1.05 g, 4 mmol), and trimethyl methylenediphosphonate (26) (0.88 g, 4 mmol) in THF (10 
mL) diisopropylazodicarboxylate (1 mL, 5 mmol) was added dropwise. The reaction was further refluxed for 2 
h, cooled to RT and concentrated. The residue was purified by flash chromatography in DCM-MeOH 0 10 % 
to give 0.89 g (1.84 mmol, 92 %) of the target product as a mixture of two isomers on the -phosphorous atom.
 HRMS (positive) m/z 501.1478; expected for C17H31N2O11P2 [M+H]+ 501.1403.
1H NMR (500 MHz, CDCl3)  10.20 (2d, 1H), 7.43 (d, J = 2.8, 0.5H), 7.41 (d, J = 2.7, 0.5H), 5.73 (d, J = 2.3, 
0.5H), 5.69 (d, J = 2.3, 0.5H), 5.67 (d, J = 5.8, 0.5H), 5.65 (d, J = 5.8, 0.5H), 4.94 – 4.91 (m, 1H), 4.86 (dd, J = 
6.4, 3.7, 0.5H), 4.82 (dd, J = 6.5, 3.5, 0.5H), 4.34 – 4.22 (m, 3H), 3.76 – 3.74 (m, 4.5H), 3.73 – 3.72 (m, 4.5H), 
2.50 (dt, J = 21.2, 1.2, 2H), 1.49 (s, 3H), 1.27 (s, 3H).
13C NMR (126 MHz, CDCl3)  163.89, 150.36, 142.41, 142.33, 114.29, 102.49, 93.64, 93.30, 85.27, 85.22, 84.11, 
80.50, 80.41, 77.50, 65.88, 65.82, 65.77, 53.42, 53.33, 53.27, 53.21, 52.44, 52.39, 26.97, 25.13, 23.66 (dt, J = 
137.6, 8.2).
31P NMR (202 MHz, CDCl3)  21.81 (d, J = 6.4), 21.76 (d, J = 6.4), 21.70 (d, J = 6.4), 21.41 (d, J = 6.4).
Compound 3: A solution of 2 (0.48 g, 1 mmol) in DCM (10 mL) and aqueous 90 % trifluoroacetic acid (2 mL) 
was kept at RT for 1 h and concentrated. The residue was co-evaporated with toluene (22 mL). The final residue 
was purified by flash chromatography in DCM-MeOH 115 % to give 0.379 g (0.85 mmol, 85 %) of the 
intermediate diol. A solution of the above material (0.379 g, 0.85 mmol) in pyridine (5 mL) was treated with iso-
butyric anhydride (0.415 mL, 2.5 mmol) in the presence of 4-(dimethylamino) pyridine (0.012 g, 0.1 mmol) at 
RT for 5 h. The reaction was quenched with MeOH (0.5 mL), kept for 10 min and concentrated. The residue was 
dissolved in DCM and washed successively with 1 M HCl, water, and a mixture of NaHCO3 saturated solution 
and brine. The organic layer was dried and concentrated. The residue was purified by flash chromatography DCM-
MeOH 16 % to give 0.43 g (0.74 mmol; 87 %) of the target compound (two isomers on -phosphorous atom).
HRMS (positive) m/z 858.1673; expected for C21H35N2O13P2 585.1614 [M+H]+ 585.1614.
1H NMR (500 MHz, CDCl3)  10.10 (2d, 1H), 7.74 (d, J = 8.2, 0.5H), 7.67 (d, J = 8.2, 0.5H), 6.13 (dd, J = 6.6, 
1.3, 0.5H), 5.77 (dd, J = 8.1, 1.9, 0.5H), 5.73 (dd, J = 8.1, 1.9, 0.5H), 5.44 (dd, J = 5.9, 3.7, 0.5H), 5.37 (dd, J = 
5.9, 3.5, 0.5H), 5.30 (t, J = 6.2, 0.5H), 5.25 (t, J = 6.4, 0.5H), 4.45 – 4.41 (m, 0.5H), 4.39 – 4.32 (m, 1H), 4.24 – 
4.20 (m, 1H), 3.82 – 3.74 (m, 9H), 2.62 – 2.46 (m, 4H), 1.14 (bs, 3H), 1.13 (bs, 3H), 1.10 – 1.07 (m, 6H).
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713C NMR (126 MHz, CDCl3)  175.79, 175.69, 175.51, 163.39, 163.36, 150.69, 150.65, 140.07, 139.99, 103.50, 
103.36, 86.13, 85.89, 81.21, 81.15, 81.04, 80.98, 77.37, 72.38, 72.31, 69.91, 69.87, 65.37, 65.34, 53.33 (m), 33.65, 
33.54, 23.93 (dt, J = 137.3, 14.2) 18.82, 18.71, 18.63.
31P NMR (202 MHz, CDCl3)  22.44 (d, J = 7.3), 21.87 (d, J = 6.6), 21.46 (d, J = 7.3), 21.41 (d, J = 6.7).
Compound 4: To a solution of 3 (0.06 g, 0.1 mmol) in acetonitrile (1 mL) bromotrimethylsilane (0.13 mL, 1 
mmol) was added at RT and the reaction was kept for 2 h. The reaction was concentrated and the residue was co-
evaporated with aqueous MeOH (10:1) (1 mL). The residue was co-evaporated with toluene (21 mL) to remove 
traces of water. The residue was dissolved in anhydrous MeOH (1 mL) and treated with a 25 % stock solution of 
NaOMe (0.05 mL) at room temperature (RT) for 3 h. The reaction was quenched with Dowex50W8-Et3NH+. The 
resin was filtered off and the filtrate was concentrated. The residue was dissolved in water and freeze-dried to 
give 0.072 g (0.1 mmol) of the target compound as a fluffy white solid.
HRMS (negative) m/z 401.0149; expected for C10H15N2O11P2 [M-H]- 401.0151
1H NMR (500 MHz, MeOD)  7.76 (d, J = 8.1, 1H), 5.73 (d, J = 4.6, 1H), 5.71 (d, J = 8.1, 1H), 4.14 (dt, J = 9.8, 
5.2, 2H), 4.05 – 4.00 (m, 1H), 3.98 – 3.87 (m, 2H), 2.96 (q, J = 7.3, 12H), 1.97 (dd, J = 27.1, 11.5, 2H), 1.03 (t, J 
= 7.3, 18H).
13C NMR (126 MHz, MeOD)  166.20, 151.74, 141.81, 102.46, 88.37, 83.31 (d, J = 7.6), 73.69, 69.54, 63.28 (d, 
J = 4.3), 46.57, 27.19 (t, J = 125.0), 8.
31P NMR (202 MHz, MeOD)  16.43, 14.2.
Compound 5: To a solution of 4 (0.072 g, 0.1 mmol) in DMF (1.5 mL) was added N, N´-carbonyldiimidazole 
(0.057 g, 0.35 mmol) and the mixture was stirred for 3 h at RT. The reaction was quenched by addition of MeOH 
(0.01 mL) and concentrated. The residue was co-evaporated with DMF (2×1mL) and dissolved in a fresh portion 
of DMF (1 mL). A 0.5 M solution of tributylammonium phosphate in DMF (1 mL) was added to the above 
solution at RT, which resulted in immediate formation of white precipitate. The reaction was further stirred at RT  
for 16 h. The reaction was diluted with water (2 mL) and concentrated. The residue was dissolved in water and 
purified by ion-exchange chromatography using Fast Flow Sepharose Q (15×200 column); linear gradient 
NH4HCO3 0.04 to 0.4 M, flow-rate 5 mL/min; detection on 214 and 254 nm. The appropriate fractions were 
pooled and freeze-dried to give 0.0085 g (0.015 mmol, 15 %) of the target compound as white fluffy substance.
HRMS (negative) m/z 480.9857; expected for C10H16N2O14P3 [M-H]- 480.9814.
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81H NMR (500 MHz, D2O)  7.89 (d, J = 8.1, 1H), 5.85 – 5.81 (m, 2H), 4.29 – 4.25 (m, 2H), 4.13 (d, J = 1.9, 1H), 
4.10 – 4.01 (m, 2H), 2.29 – 2.18 (dt, J = 21, 2, 2H).
31P NMR (202 MHz, D2O)  17.80 (d, J = 9.3), 6.18 (dd, J = 23.6, 9.3), -9.25 (d, J = 23.6).
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9RESULTS AND DISCUSSION
AfUAP1 undergoes large conformational changes during catalysis
To explore UAP1 catalytic mechanism and provide a structural framework for the design and optimization of 
inhibitors, crystal structures of AfUAP1 in complex with substrates/products were determined. Initially, a high-
resolution dataset of a Michaelis complex of the enzyme at 1.75 Å was trapped using crystals grown in the 
presence of UDP-GlcNAc and subsequently soaked with PPi and Mg2+ (Table 1 and Figure 2; RMSD of 1.6 Å 
on C atoms compared to the “apo-like” structure described earlier with PDB 4BMA (13)). One of the two protein 
molecules in the asymmetric unit showed an empty active site, and is considered here as the “apo-like” form 
(Figure 2). To understand the catalytic mechanism, two further complexes were also determined – a substrate 
complex with GlcNAc-1P and a substrate complex with UTP (Table 1 & Figure 2).
   The overall structure of AfUAP1 is similar to that previously described for eukaryotic UAP1s CaUAP1(11) and 
HsUAP1(12) ( Figures 3A and 3B). AfUAP1 and CaUAP1 share 52% sequence identity (Figure S1) and 
superposition of the overall structures of these two proteins reveals an RMSD of 1.1 Å (on all C atoms), 
indicating a similar overall structure. AfUAP1 possesses a three-domain fold with the central catalytic domain 
flanked by two domains of unknown function (Figure 2A). While the N-terminal domain of AfUAP1 consists 
entirely of four -helices (Figure 2A), the central domain consists of seventeen -strands and twelve helices 
adopting the Rossmann fold. The C-terminal domain consists of four short -strands and a long helix that connects 
to the central domain (Figure 2A).  AfUAP1 has a large active site cleft, with its wall being formed by the central 
domain and the C-terminal domains (Figure 2). Ligand binding at the bottom of the active site induces a number 
of significant conformational changes compared to the “apo-like” structure. The binding of GlcNAc-1P to 
AfUAP1 is stabilized by hydrogen bonds with Asn249, Gly316, Tyr330, Glu329, Asn355 and Lys437. 
Interestingly,  a PO43- molecule which occupies the same position as the UTP -phosphate interacts with R141 
and T140 (Figures 2B, 2C and 4) and induce a shift of loops A, B, C, D and * on the central domain, closing the 
active site (Figures 2A and 2B) (RMSD vs. “apo-like” structure = 2.1 Å on all C atoms). Similar interactions 
were seen in the CaUAP1-GlcNAc-1P complex with equivalent residues (Tyr310, Asn227, Glu309, Gly294, 
Asn335, and Lys421) except for the absence of the PO43- molecule, which prevents the ordering of R116 (R141 
in AfUAP1)(Figures 3C and 3D) (11). We hypothesise that in the absence of this PO43-  molecule, the binding of 
GlcNAc-1P alone would only cause partial closure of the active site. In contrast, UTP appears to bind AfUAP1 
with no significant conformational changes (RMSD vs. “apo-like” structure = 1.1 Å on all C atoms), interacting 
with Gly136, Gln138, Gly139, Thr140, Lys148, Arg141, Gln222, Gly248, Cys277 and Lys383 (Figures 2B, 2C 
and 4). However, binding of UDP-GlcNAc, magnesium and PPi to the enzyme causes a considerable change to 
the overall structure of the protein (Figures 2B, 2C and 3) (RMSD vs. “apo-like” structure = 2.1 Å on all C 
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atoms). UDP-GlcNAc binds to the enzyme with the GlcNAc and uridine moieties of the molecule occupying 
positions equivalent to GlcNAc-1P (max. atomic positional shift = 0.6 Å) and UTP (max. atomic positional shift 
= 1.0 Å), also establishing similar hydrogen bonding interactions (Figures 2B, 2C and 4). Further hydrogen bonds 
are established between  and  phosphates of UDP-GlcNAc and Arg141 and Lys437 (Figure 4). The PPi 
molecule occupies a position approximately equivalent to the  and -phosphates of UTP (max. positional shift 
on phosphorus atoms = 1.5 Å), and is tethered by interactions with positively charged residues, such as Arg141, 
Lys437 and Lys148 (Figure 4). A comparison of AfUAP1-UDP-GlcNAc-Mg+2-PPi and CaUAP1-UDP-GlcNAc 
complexes reveals that UDP-GlcNAc occupies the same position and makes identical interactions with equivalent 
residues in both enzymes (Figures 3C and 3D) (11). Interestingly a SO42- ion occupies the same position as one 
of the phosphates of the PPi seen in the AfUAP1-UDP-GlcNAc-PPi-Mg2+ complex (Figures 4 and 3D). Taken 
together, it appears that to accommodate substrates and release products, AfUAP1 undergoes large conformational 
changes during catalysis. 
The Mg2+ ion aligns the reactants for catalysis
Several reports have shown that UAP1 requires divalent cations, such as Mg2+, for full activity (7, 11, 12). The 
UDP-GlcNAc-PPi-Mg2+ Michaelis complex of the reverse reaction trapped here reveals the key role the metal 
plays in coordinating the reactants/products (Figures 4 and 5). The magnesium ion with an occupancy of 1.0, is 
pentacoordinated by the phosphate groups of pyrophosphate, UDP-GlcNAc and two water molecules in a 
tetragonal bipyramidal arrangement (distances ranging between 2.0 and 2.4 Å) while the 6th ligand is absent 
(presumably a disordered water molecule), providing the necessary geometry to place the attacking oxygen of 
pyrophosphate within 2.2 Å distance (angle of attack 166o) from the UDP-GlcNAc -phosphate (Figure 5A), 
compatible with a direct displacement mechanism (Figure 4). Interestingly, the high-resolution electron density 
map also reveals an alternative conformation for the UDP-GlcNAc -phosphate that flips 1.7 Å resulting in an 
“off conformation”, and placed 3.5 Å from the PPi oxyanion (Figures 4 and 5). It is possible that this “off 
conformation” resembles the product of the forward synthesis preceding a conformation that is the Michaelis 
complex of the reverse pyrophosphorolysis reaction. Interestingly, superposition of two separate CaUAP1-UDP-
GlcNAc complexes (pdb entries 2yqs and 2yqj (11)) reveals a similar dual conformation as observed in  the 
AfUAP1-UDP-GlcNAc-PPi-Mg2+ complex described here (Figure 3E and 3F). The role of the metal is firstly to 
correctly align the UTP with  GlcNAc-1P, and UDP-GlcNAc with PPi, and secondly, to facilitate close proximity 
of the negatively charged phosphate groups. Similarly, Pelissier et al. (27) also proposed that Mg2+ prevents 
electrostatic repulsion between phosphate groups of the substrates Man-1P and GTP of the thermophilic 
bacterium Thermotoga maritima pyrophosphorylase. Thus, the Mg2+ ion aligns the reactants for catalysis.
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A conserved lysine occupies the position of a second metal ion in GlmU
The structure suggests that the reverse (pyrophosphorolysis) reaction may be facilitated by an increase in 
electrophilicity of the -phosphorus induced by a salt bridge interaction between a lysine that is conserved in 
eukaryotes (Lys437 in AfUAP1, Figure S1) and the  phosphate of UDP-GlcNAc (Figure 5). Similarly, Lys437 
may facilitate the forward reaction by inducing an increase of the electrophilic character of the UTP -phosphorus 
(Figure 5). 
   Recently the structures of a ternary complex of a bacterial UAP from M. tuberculosis named MtGlmU, and 
other classes of nucleotidyltransferases (28, 29), revealed an unusual catalytic mechanism dependent on two-
metal-ions (30) (Figures 4 and 5B). GlmUs are bacterial enzymes with two domains catalysing two independent 
reactions. While the C-terminal domain catalyses an acetyltransfer reaction from acetyl-CoA to glucosamine-1P 
(GlcN-1P) to form N-acetylglucosamine-1P (GlcNAc-1P), the N-terminal domain possesses uridylation activity 
converting GlcNAc-1P to UDP-GlcNAc in the presence of UTP (30). In the MtGlmU structure, UDP-GlcNAc 
and PPi interact through hydrogen bonds with Ala14, Gly17, Thr18, Gln83, Gly88, Thr89, Gly151, Glu166 and 
Asn181, and salt bridges with Lys26 and Arg19 (Figure 4). The magnesium atom in both the AfUAP1 and 
MtGlmU ternary complexes occupy similar positions but they differ in how they are coordinated (Figure 5). The 
metal ion in AfUAP1 is pentacoordinated, whereas the magnesium atom in GlmU is hexacoordinated by the 
phosphate groups of PPi and UDP-GlcNAc, and three water molecules (Figure 5). The average bond angle of 
coordination of magnesium in the AfUAP1_UDP-GlcNAc-PPi_Mg2+ complex is 89  10o while in the MtGlmU-
UDP-GlcNAc-PPi-Mg2+-Co2+ complex it is 90  17o. A comparison of the angles of magnesium coordination in 
AfUAP1 and MtGlmU complexes is shown in Table 2.  With respect to the reaction mechanism, the pyrophosphate 
is within 2.8 Å (with an angle of attack of 169o) from the UDP-GlcNAc -phosphate and therefore at a distance 
not as optimal as that found in the Michaelis complex of AfUAP1, suggesting that a positional shift of 
UDP-GlcNAc -phosphate might be required in order to facilitate catalysis (Figure 5A). 
  Interestingly, the crystal structure reveals the presence of a second metal in the MtGlmU identified as cobalt, 
although experiments in solution confirm that GlmU requires two magnesium ions for catalysis (30). Furthermore, 
this second metal binding site is found in a position occupied by Lys437 in AfUAP1 (Figures 4 and 5B). In the C. 
albicans UAP1 crystal structure, Lys421 occupies a similar position and was also predicted to play the role of the 
second metal ion (11).  In Leishmania major UDP-glucose pyrophosphorylase (31) and a bacterial GDP-mannose 
pyrophosphorylase (27), a lysine was also observed to occupy the position of the second Mg2+ seen in C. 
glutamicum UGP (29).  It is possible that bacterial GlmUs and eukaryotic UAP1s follow a similar catalytic 
mechanism but differ in the number of metal atoms and consequently in how the electrophilic character of -
phosphorous is enhanced. In eukaryotes a single magnesium atom is essential for the reaction while the position 
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of the second magnesium atom present in bacteria is occupied by a basic amino acid. Thus, a conserved lysine in 
AfUAP1 occupies the position of a second metal ion in GlmU.
 
Lys437 is required for AfUAP1 catalysis
Several of the amino acid residues (e.g. equivalents of Thr140, Arg141 and Lys148 in AfUAP1, Figure 4) shown 
to bind the phosphates of nucleotides/phosphosugars in complexes with other UAP1 enzymes have been mutated 
previously and shown to be important for substrate binding/catalysis (7). However, to probe the role of Lys437 
in catalysis, we carried out site-directed mutagenesis of this basic residue and two other amino acids involved in 
stabilization of substrates/products (7, 11, 12). The mutants have the same expression levels as the wild type 
enzyme as confirmed by SDS-PAGE  (Figure S2A). As mentioned earlier, Lys437 makes direct contacts with the 
phosphate group of GlcNAc-1P (Figure 4) and with the  and -phosphate of UDP-GlcNAc (Figure 4). Tyr330 
establishes a hydrogen bond with the phosphate group of GlcNAc-1P, and Lys148 is involved in UTP binding, 
contacting the phosphate groups of UTP and pyrophosphate (Figure 4) through direct and indirect hydrogen 
bonds. In agreement with the structural data, the K148M and Y330F mutants affect the Km values of UTP (10-
fold increase) and GlcNAc-1P (6-fold increase), respectively (Table 3). The K437A mutant shows an increase in 
the Km values of both substrates (32 and 10-fold increase in the Kms of GlcNAc-1P and UTP respectively), which 
may be the result of disrupting the interaction of Lys437 with the phosphate groups of GlcNAc-1P and UDP-
GlcNAc (Figure 4). To probe the effect of this residue further we made  K437R and K437M mutants. The K437R  
mutant shows a slight increase in Km by 5- and 4-fold for GlcNAc-1P and UTP, respectively while the K437M 
mutant completely abolishes enzyme activity (Table 3 and Figure S2B). The increase in activity by the K437R 
mutant compared to the K437A could be as a result of the arginine mimicking the positive charge present on 
Lys437, which is essential for an optimal catalytic efficiency. However, the activity of K437R is 2.9-fold lower 
than the wild type enzyme likely due to the bulkier arginine side chain not being positioned optimally with respect 
to the -phosphate group of either UTP or UDP-GlcNAc. Overall, all the four mutants reduce kcat (Table 3). Out 
of the five mutants tested, K437A has the largest effect on catalytic efficiencies with a 433 and 117-fold reduction 
towards GlcNAc-1P and UTP, respectively (Table 3) and K437M completely inactivates the enzyme. Therefore, 
our data suggest that these residues play key roles in aligning the substrates for UAP1-catalyzed UDP-GlcNAc 
synthesis/pyrophosphorolysis, in particular supporting the role of Lys437 as being essential for catalysis in line 
with the proposed catalytic mechanism (Figure 5C). 
Design and synthesis of meUTP as a mechanism-inspired inhibitor 
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We attempted to use the AfUAP1 structural/mechanistic insights generated here to design a mechanism-inspired 
substrate analogue inhibitor. The AfUAP1-UDP-GlcNAc-PPi Michaelis complex (Figure 4) and the proposed 
reaction mechanism (Figure 5) reveal the direct attack of the phosphate group of GlcNAc-1P on UTP , -
phosphodiester bond leading to the formation of the products UDP-GlcNAc and PPi. This suggests that an ,-
methylenebisphosphonate analogue of UTP (meUTP)  in which the scissile , -pyrophosphate bond is replaced 
with a methylenebisphosphonate could inhibit this forward reaction (Figure 6A). Synthesis of this analogue was 
initiated with the preparation of a fully protected UDP methylenebisphosphonate analogue 2 (Scheme 1) using a 
variant of Mitsunobu esterification of 2, 3-O-isopropylideneuridine with methylenebisphosphonic acid 
trimethylester as a key step (Scheme 1) (26). In these conditions, the target compound was obtained in 90% yield 
on a gram scale after conventional chromatography. This novel and highly effective method offers valuable 
advantages over the reported procedure for direct synthesis of nucleoside 5-methylenebisphosphonates, which 
requires large excess of methylenebisphosphonic acid tetrachloride (32) to be used to minimize formation of 
symmetrical and/or cyclic by-products. According to the initial synthetic plan, compound 2 was converted into 
the 2, 3-di-O-isobutyrate derivative 3 in a two-step protective group exchange (Scheme 1). Unfortunately, all 
attempts to perform selective mono demethylation at the terminal phosphorous atom of the methylene 
bisphosphonate moiety in 3 to ensure regioselective formation of the triphosphate bond were unsuccessful. After 
some experimentation, conventional phosphorylation of the fully deprotected , - methylenebisphosphonate 
UDP analogue 4 was proven to be the easiest way to reach the target molecule. To this end, stepwise removal of 
the protecting groups from 3 gave rise to 4 in near quantitative yield. Finally, phosphorylation of 4 with N, N´-
carbonyldiimidazole and tributylammonium phosphate in DMF for 16 h furnished the desired compound 5 or  
meUTP (Figure 6A) in a modest 15 % yield after ion-exchange chromatography. The structure of compound 5 
was ultimately confirmed by 31P NMR, with the spectrum showing the characteristic pattern of three different 
phosphorous signals as doublet at  17.8 (J = 9.3), doublet of doublets at  6.18 (J = 23.6, 9.3), and doublet at  -
9.25 (J = 23.6) corresponding to   , and  phosphorous atoms only compatible with the linear phosphate-
methylenebisphosphonate structural motif. The HPLC profile of the purified compound 5 (Figure S3A) reveals 
the content of the main substance no less than 98% along with a contamination (2%) corresponding to meUDP.
   Initial experiments showed that AfUAP1 was unable to utilize the meUTP as substrate. Therefore, potential 
inhibition by this compound was studied by an HPAEC assay, allowing us to follow the conversion of UTP to 
UDP-GlcNAc. Using this approach, it was observed that at increasing concentrations of the meUTP, less UTP is 
consumed while the amount of UDP-GlcNAc produced decreases, suggesting that meUTP is an AfUAP1 inhibitor 
(Figure 6B). We have noted that while the concentration of the inhibitor increases, a peak at Rt = 3.33 min 
corresponding to meUDP impurity also increases steadily. At 200 µmol concentration of the inhibitor the 
estimated concentration of meUDP reaches about 10-15 µmol, which was deduced from the comparison of the 
Page 16 of 60RSC Chemical Biology
14
areas under the meUDP, UDP-GlcNAc, and UTP peaks. This estimation exceeds the calculated concentration of 
meUDP impurity based on 2% contamination of the meUTP 2 to 3 folds. It is not clear if this is a result of 
enzymatic conversion of meUTP or whether the meUDP level increases due to partial hydrolysis of the inhibitor 
in mildly basic conditions of the reaction quench/sample processing. Additionally, a peak at Rt = 3.80 min was 
identified as UDP and probably originates from the similar decay of UTP during processing of the enzymatic 
reaction. To rule out whether meUDP is the source of the observed enzyme inhibition, we showed that AfUAP1 
is not inhibited by  500 µM meUDP (Figures S3B and C), eliminating this possibility. 
   The data show that the  -methylenebisphosphonate UTP analogue 5 (meUTP) inhibits AfUAP1 activity with 
an IC50 of 115 ± 40 M (Figure 6C), representing one of the few examples of a rationally designed inhibitor of 
this class of enzyme. Although this compound is likely to be an aspecific inhibitor of UAP1s and other UTP-
dependent enzymes, further structural modifications guided by small differences between the human and the 
fungal enzymes (13) may lead to development of selective inhibitors of  fungal UAP1. The possibility of inhibition 
of specific UAP1s, despite high sequence conservation in this family, has recently been demonstrated with a 
selective UTP-competitive inhibitor of T. brucei UAP1 (TbUAP1) (10). This inhibitor was shown to compete 
with UTP, binding with a KD of 9.3 µM (IC50 of 37 ± 4 µM), making it more potent than the meUTP (10). In 
addition, the TbUAP1 inhibitor was selective towards this parasite enzyme because it binds to a unique allosteric 
site on TbUAP1 that is not present in either the human or the fungal UAP1. 
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CONCLUDING REMARKS
The structural data described here provide detailed snapshots of the enzyme in complex with substrates/products, 
revealing for the first time the key role that the magnesium ion plays in stabilizing the Michaelis complex of 
pyrophosphorolysis, aligning the reactants for a direct attack by the pyrophosphate group, in parallel with 
significant conformational changes in the enzyme. We also show that eukaryotic UAP1s depend solely on one 
magnesium ion unlike the bacterial GlmUs that require two magnesium ions for catalysis. Conserved amino acids 
interacting with the negative charges on the phosphates were shown to be important for full catalytic activity and 
in particular we demonstrated that eukaryotic UAP1s use a conserved lysine (Lys437 in AfUAP1) as a key electron 
withdrawer to increase the electrophilic character of the -phosphorous of either UTP or UDP-GlcNAc in order 
to promote the forward or reverse catalytic reaction respectively. Furthermore, we have reported for the first time 
that an ,-methylenebisphosphonate UTP analogue (meUTP) inhibits AfUAP1 with an IC50 of 115 M. This 
and its derivatives may also be a useful reagent for the study of the broader family of sugar nucleotide 
pyrophosphorylases. For example, it could be used in kinetic protein crystallography experiments that could help 
to trap kinetic states of pyrophosphorylases, and to determine the outcome of inhibiting these enzymes in 
appropriate cell models. Together, the novel mechanistic insights and the substrate-based inhibitor reported here 
will aid the future exploitation of this genetically validated enzyme as a potential target for the discovery of novel 
antifungal compounds. 
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FIGURE LEGENDS
Figure   1: UDP-GlcNAc biosynthetic pathway. The four main enzymes of the pathway are coloured in red. 
Metabolites feeding the pathway are in blue and the final product of the pathway is coloured in pink. The various 
fates of UDP-GlcNAc are linked by the branching arrows.
Figure 2: Ligand-induced conformational changes of AfUAP1. (A) Cartoon representation of AfUAP1, the N-
terminal domain is coloured red, the C-terminal domain is coloured blue and the pyrophosphorylase domain is 
coloured in grey. Loops A, B, and C-D together with * are coloured in yellow, cyan and pink, respectively. The 
flexible regions are indicated by red arrows. (B) Cartoon representation of the superposed “apo-like” structure 
with the different complexes showing a large area around the active site. While the colours for the mobile regions 
are maintained for the “apo-like” structure, the same loops and * are coloured in orange in the different 
complexes. (C) The surface representation shows conformational changes around the active site in the various 
AfUAP1 complexes. The substrates and the products are shown as sticks, the Mg2+ ion is shown as a blue sphere. 
Figure 3: Comparison of AfUAP1 with other UAP1s. (A). Overall structure of CaUAP1. Coloured in orange, 
cyan and purple are the N-terminal, catalytic and C-terminal domains, respectively. (B) Overall structure of 
HsUAP1. Coloured in red, green and blue are the N-terminal, catalytic and C-terminal domains, respectively. (C) 
Active site of CaUAP1with GlcNAc-1P bound. Active site residues are shown in sticks. Hydrogen bond 
interactions are shown as black dashes. (D) Active site of CaUAP1with UDP-GlcNAc-SO42- bound. Active site 
residues are shown in sticks. Hydrogen bond interactions are shown as black dashes. SO42- is shown as sticks. (E) 
Stick representation of UDP-GlcNAc in the AfUAP1-UDP-GlcNAc-PPi-Mg2+ ternary complex, showing the 
observed dual conformation around the -phosphate. (F) Superposition of UDP-GlcNAc from the CaUAP1-
UDP-GlcNAc product complex (pdb: 2yqs, blue) with UDP-GlcNAc from the CaUAP1-UDP-GlcNAc reaction-
completed product complex (pdb: 2yqj, green). This superposition recapitulates the dual conformation observed 
in the AfUAP1-UDP-GlcNAc-PPi-Mg2+ complex.
Figure 4:  Active site of  AfUAP1 complexes and comparison with the MtGlmU ternary complex. Amino 
acids and ligands are shown as sticks with grey and green carbon atoms respectively. Water molecules, Mg2+ and 
Co2+ atoms are shown as spheres in red, blue and pink respectively. Hydrogen bonds and metal coordination are 
represented with dotted lines coloured black and orange respectively. The unbiased |Fo |-|Fc | calc electron density 
maps for the ligands is shown in blue, contoured from 2.2 to 2.5 depending on the ligand. The blue characters 
indicate the residues mutated in the mutagenesis assay.
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Figure 5: Magnesium coordination and AfUAP1 mechanism. (A) Magnesium coordination in the AfUAP1-
UDP-GlcNAc-PPi-Mg2+ complex active site. A view of the active site of the AfUAP1-UDP-GlcNAc-PPi–Mg2+ 
and MtGlmU-UDP-GlcNAc-PPi–Mg2+-Co2+complexes. The attack distance for pyrophosphorolysis is 2.2 and 2.8 
Å and the attack angle is 166o and 169o for UAP1 and GlmU, respectively. The distance between the -phosphates 
in both UDP-GlcNAc adopting the dual conformation is 1.7 Å. The Mg2+ is tetragonal bipyramidally coordinated 
(albeit with a disordered 6th ligand in AfUAP1) as suggested by coordination distances and angles. (B). 
Magnesium coordination in the MtGlmU-UDP-GlcNAc-PPi–Mg2+-Co2+ complex active site. (C) Schematic 
diagram of the proposed forward and reverse reaction mechanisms. The left panel indicates chemical bond 
formation/cleavage (cyan arrows) in the AfUAP1-PPi-UDP-GlcNAc ternary complex shown in Fig. 5A leading 
to the formation of GlcNAc-1P and UTP.  The right panel using the same ternary complex structure as a template 
indicates chemical bond formation/cleavage in the reverse reaction leading to the formation of UDP-GlcNAc and 
PPi from GlcNAc-1P and UTP is proposed.
Figure 6: Kinetic characterization of meUTP (compound 5). (A) Chemical structures of UTP and  meUTP. 
The α, β-methylenebisphosphanate is indicated in red.  (B) HPAEC chromatogram of AfUAP1 inhibition 
by  meUTP, where [UTP] ≈ Km and [GlcNAc-1-P] is in excess. The inhibitor concentration is indicated on each 
curve (0 - 200 µM). The reaction mixtures (20 µM UTP, 50 µM GlcNAc-1P, 1 mM DTT, 5 nM enzyme, 50 mM 
Tris-HCl pH 8.0, 10 mM MgCl2 and 2 % glycerol, total volume 100 µl) with and without varying concentrations 
of the inhibitor  were incubated for 30 min and the reactions were terminated by the addition of 10 µl of 0.1 M 
NaOH(~10 mM final concentration)  prior to analysis on a CarboPac-PA-1 column (Dionex) equilibrated with a 
80:20 mixture of 1 mM NaOH  and a 1:1 mixture of 1 mM NaOH and 1 M sodium acetate. The eluent was 
monitored at 260 nm and peaks were identified by comparison to standards. (C) IC50 curves of  meUTP with fixed 
[UTP] and [GlcNAc-1P] and varying concentration of inhibitor.
Figure S1: Multiple sequence alignment of UAP1s with MtGlmU. Multiple sequence alignment of AfUAP1, 
the human AGX1 and AGX2 isoforms, C. albicans UAP1 (CaUAP1) and MtGlmU. Secondary structure elements 
from the AfUAP1 structure are shown with -helices and -strands in red. The key highly conserved lysine in 
eukaryotes (Lys437 in AfUAP1) is highlighted in cyan and indicated with a green inverted triangle. The insertion 
loop is underlined and AfUAP1 loops are indicated with a line and labelled appropriately as well as helix *.
Figure S2: Role of K437 in catalysis. (A) SDS-PAGE of all mutants. 1. WT, 2. K437A, 3. Y330F, 4. K148M, 
5. K437R. All proteins were overexpressed and in the soluble fraction. (B) Activity of K437A,  K437R and 
K437M compared to the wild type. Experiment was done in triplicates and result expressed as mean  SEM. The 
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Biomol Green assay was performed as described in the Materials and Methods using equal enzyme concentration 
of 20 nM enzyme, 300 µM UTP and 250 µM GlcNAc-1P terminating after 20 min. 
Figure S3: (A). HPLC chromatogram of meUTP. The major component (meUTP) has a retention time of 6.94. 
The residual peak of meUDP has a retention time of 3.56 min. The major compound comprises 98% of the 
mixture. (B).  AfUAP1 activity in the absence of meUDP. To investigate the effect of meUDP an HPLC assay 
was performed (Waters Xselect 150 × 4.6 mm column, flow rate 1 mL/ min. Buffer A 100 mM phosphate 
/ 2.5 mM Bu4HSO4 in water; Buffer B 100 mM phosphate/ 2.5 mM Bu4HSO4 in water-MeCN 1:1). The 
assay was performed using 5 nM enzyme, 25 µM UTP and 50 µM GlcNAc-1P, for 10 min. The 
chromatogram shows the production of UDP-GlcNAc (Rt = 4.5 min). It also shows a peak 
corresponding to UDP (Rt = 5.55 min) which is thought to be a result of gradual hydrolysis of UTP. The 
remaining UTP elutes at Rt = 9.5 min. (C). Effect of meUDP on AfUAP1 activity. The experiment was 
done as described for B in the presence of 500 µM meUDP. The chromatogram shows meUDP elutes at 
Rt = 3.56 min; concentration far above the scale. Production of UDP-GlcNAc (Rt = 4.5 min) remains 
unaffected. It also shows a peak corresponding to UDP (Rt = 5.55 min) which is taken to be a result of 
gradual hydrolysis of UTP. The remaining UTP elutes at Rt = 9.44 min. 















































































Scheme 1: Synthesis of α,β-methylenebisphosphanate UTP analogue (meUTP). Reagents and 
conditions: i) DIAD, PPh3, trimethyl methylenediphosphonate, THF, 2 h, reflux, 92%; ii) (a) TFA-H2O 
(9:1), DCM, 2 h, RT, 85%, (b) (i-PrCO)2O, Py, DMAP, 5 h, RT, 87%; iii) (a) TMSBr, MeCN, 1 h, RT, (b) 
MeOH, MeONa, then Dowex50W8-Et3NH+, quant; iv) Im2CO, DMF, then (Bu3NH)3PO4, 16 h RT, ion-
exchange chromatography, 15%. 
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Resolution (Å) 20.0 (1.81 - 1.75) 20.0 (2.36 - 2.28) 20.0 (2.49 - 2.40)
Space group P212121 P212121 P212121
Unit cell
a (Å) 55.2 55.7 55.6
b (Å) 139.8 138.1 140.0
c (Å) 144.6 145.1 146.3
 =  =  () 90 90 90
No. of reflections 441409 157074 177172
No. of unique 
reflections
113044 49491 46020
I/ (I) 16.4 (2.4) 11.2 (2.4) 13.7 (3.2)
Completeness (%) 99.1 95.5 99.2
Redundancy 3.9 (3.8) 3.2 (3.0) 3.8 (3.0)
Rmerge (%) 5.8 (56.8) 11.6 (39.2) 8.6 (32.5)
RMSD from ideal 
geometry
Bond distance (Å) 0.008 0.009 0.010
Bond angle () 1.08 1.0 1.23
Rwork (%) 21.0 20.6 22.7
Rfree (%) 24.0 25.9 27.7
No. of residues 925 905 928
No. of water mol. 559 231 120
B-factors (Å2)
Overall 23.8 48.6 34.8
Protein 23.4 48.8 34.8









Values in parenthesis are for the highest resolution shell. All measured data were included in the refinement.
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 Table 2: Measurements of angles between Mg2+ and ligands in the AfUAP1-UDP-GlcNAc-PPi-Mg2+ 
and MtGlmu-UDP-GlcNAc-PPi-Mg2+-Co2+  complexes
AfUAP1-UDP-GlcNAc-PPi-Mg2+ MtGlmu-UDP-GlcNAc-PPi-Mg2+-Co2+
Atoms Angle (o) Atoms Angle (o)
W1Mg2+W2 100.1 W1Mg2+W2 80.7
W1Mg2+W3 nd W1Mg2+W3 103.3
W1Mg2+OBH 87.9 W1Mg2+O1A 88.7
W1Mg2+OAB 105.2 W1Mg2+O1 107.9
W3Mg2+OAA nd W3Mg2+O5 69.6
W3Mg2+W2 nd W3Mg2+W2 69.7
OAAMg2+OAB 79.7 O5Mg2+O1 80.0
OABMg2+OBH 82.8 O1Mg2+O1A 93.9
W3Mg2+OAB nd W3Mg2+O1 116.1
W2Mg2+OAA 76.0 W2Mg2+O5 92.1
W2Mg2+OBH 85.0 W2Mg2+O1A 76.4
OAAMg2+OBH 96.1 O1AMg2+O5 94.2
W1 = water 1, W2 = water 2 and W3 = water3 as indicated in the Figure 5. nd= not detectable due to 
absence of W3 in the AfUAP1 structure.
Table 3: Kinetic parameters of the forward reaction for the wild type and mutant forms of AfUAP1. The results 










WT 34  3 21  2 0.044  0.001 2.2  0.3 0.065 0.10
K148M 44  13 200  31 0.0074  0.0007 0.4  0.01 0.0091 0.002
Y330F 200  72 25  5 0.016  0.001 0.8  0.1 0.004 0.032
K437A 1100  900 200  62 0.0033  0.0004 0.17  0.02 0.00015 0.00085
K437R 155  29 88  12 0.027  0.003 1.3  0.1 0.008 0.015
K437M nd nd nd nd nd nd
Nd: not detectable.
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2ABSTRACT
UDP-N-acetylglucosamine pyrophosphorylase (UAP1) catalyses the last step in eukaryotic biosynthesis of 
uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc), converting UTP and GlcNAc-1P to the sugar 
nucleotide. Gene disruption studies have shown that this gene is essential in eukaryotes and a possible antifungal 
target, yet no inhibitors of fungal UAP1 have so far been reported. Here we describe the crystal structures of 
substrate/product complexes of UAP1 from Aspergillus fumigatus that together provide snapshots of catalysis. A 
structure with UDP-GlcNAc, pyrophosphate and Mg2+ provides the first Michaelis complex trapped for this class 
of enzyme, revealing the structural basis of the previously reported Mg2+ dependence and direct observation of 
pyrophosphorolysis. We also show that a highly conserved lysine mimics the role of a second metal observed in 
structures of bacterial orthologues. A mechanism-inspired UTP α,β-methylenebisphosphonate analogue (meUTP) 
was designed and synthesized and was shown to be a micromolar inhibitor of the enzyme. The mechanistic 
insights and inhibitor described here will facilitate future studies towards the discovery of small molecule 
inhibitors of this currently unexploited potential antifungal drug target.
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3INTRODUCTION
Yeast and fungi are encapsulated by a cell wall that is important for morphogenesis and provides 
chemical/mechanical protection from the environment. Fungal cell walls are composed mainly of glucans, chitin 
and mannoproteins (1). Chitin is a (1,4)-linked homopolymer of N-acetylglucosamine residues, accounting for 
only 1 – 2 % of the cell mass in yeast (2, 3), whereas the cell wall of filamentous fungi contains higher amounts 
of chitin, up to 10 – 20 % of the dry weight (4). Chitin is synthesized from UDP-GlcNAc, which is also a sugar 
donor for the synthesis of glycoproteins, glycosaminoglycans and glycosylphosphatidylinositol (GPI) anchors in 
eukaryotes as well as molecules such as lipopolysaccharide in prokaryotes.  In eukaryotes, UDP-GlcNAc is 
synthesized from fructose-6-phosphate (Fru-6P) and L-glutamine by a cascade of four enzymatic reactions 
(Figure 1); (i) conversion of Fru-6P to GlcN-6P, (ii) acetylation of GlcN-6P to GlcNAc-6P, (iii) isomerization of 
GlcNAc-6P to GlcNAc-1P, and (iv) the uridylation of GlcNAc-1P to the sugar nucleotide UDP-GlcNAc. The 
enzymes involved in this pathway are (i) GlcN-6P synthase (GFA1), (ii) GlcN-6P acetyltransferase (GNA1), (iii) 
phosphoacetylglucosamine mutase (AGM1) and (iv) UDP-GlcNAc pyrophosphorylase (UAP1) (Figure 1), 
respectively  (5). Knock out studies of any of these genes have produced lethal phenotypes in a range of eukaryotes 
(6-8), with the exception of the knockout of GFA1, which produces GlcN/GlcNAc auxotrophic mutants (9), and 
the enzymes are considered to be potential drug targets. One species-specific allosteric inhibitor has been 
described for T. brucei UAP1(10), but no mechanism-based inhibitors have so far been reported for any of the 
last three enzymes in the pathway. 
UDP-GlcNAc pyrophosphorylase (E.C.2.7.7.23) is a member of the large family of nucleotide diphosphate sugar 
pyrophosphorylases (7). Eukaryotic UDP-GlcNAc pyrophosphorylase catalyzes the synthesis of UDP-GlcNAc 
from UTP and GlcNAc-1P and also the reverse pyrophosphorolysis of UDP-GlcNAc (UTP + GlcNAc-1P  
UDP-GlcNAc + PPi). Eukaryotic UAP1s have been categorized into mammalian UAP1 and non-mammalian 
UAP1 (11). The crystal structures of the two isoforms (AGX1 and AGX2) of human UAP1 (hUAP1) were the 
first UAP1 structures to be reported (12). UAP1s consist of an N-terminal domain, a central pyrophosphorylase 
domain and a C-terminal domain. The functions of the N and C-terminal domains are not yet known (11, 12). 
Non-mammalian UAP1s possess a primary structure similar to that of mammalian UAP1s, but lack an “insertion 
loop” of more than 10 amino acids residues (11) as visualised in the crystal structures of Candida albicans and 
Aspergillus fumigatus UAP1s (CaUAP1 and AfUAP1 respectively) (Figure S1) (11, 13). Together, these human 
and C. albicans UAP1 structures, solved in complex with substrates/products, suggest an SN2 reaction mechanism 
in which phosphate oxygen of GlcNAc-1P attacks the UTP -phosphate, forming UDP-GlcNAc and releasing 
inorganic pyrophosphate (PPi). Although it has been shown that divalent cations facilitate the reactions catalysed 
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4by UAP1, their mechanistic roles are not clear, and the available structures have been determined in the absence 
of any such ions.
   Aspergillus fumigatus is the major cause of Aspergillosis, an often invasive and potentially life-threatening 
infection, found most frequently in immunocompromised patients (14, 15). As a step towards chemically 
validating A. fumigatus UDP-N-acetylglucosamine pyrophosphorylase (AfUAP1) as a potential drug target, we 
report the crystal structure of AfUAP1 in complex with the two reaction products, UDP-GlcNAc and 
pyrophosphate, and the cofactor magnesium ion, representing the first Michaelis complex for this enzyme family. 
Together with additional substrate/product complexes of this enzyme, this provides a range of snapshots of the 
reaction mechanism, revealing key conformational changes and essential participation of the magnesium ion and 
Lys437 in catalysis. A mechanism-inspired ,-methylenebisphosphonate UTP analogue (meUTP) is the first 
example of a eukaryotic pyrophosphorylase inhibitor, providing a basis for the future design of small molecule 
inhibitor for this class of enzymes. 
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5EXPERIMENTAL
Recombinant AfUAP1 production and structure determination  
 AfUAP1 was expressed as described recently (13). The protein (20 mg/ml) was co-crystallized with UTP, 
GlcNAc-1P and UDP-GlcNAc respectively by incubating the protein with 5 mM of the ligands at 4 oC for 2 h 
before setting up crystal trays.  Crystals grew after three days in a condition containing 0.2 M sodium formate 
and 20 % PEG3350. To obtain the UAP1-UDP-GlcNAc–PPi-Mg2+ ion complex, an AfUAP1-UDP-GlcNAc 
crystal was soaked for 10 seconds in a cryo-protectant (mother liquor + 10 % glycerol) containing 10 mM 
pyrophosphate and 10 mM magnesium. Prior to data collection, crystals were cryo-protected in mother liquor 
containing 10 % glycerol. Data were collected at the European Synchrotron Radiation Facility (ESRF) (Grenoble, 
France) and processed with the HKL suite(16). The AfUAP1-UDP-GlcNAc structure and other complexes 
described here were solved by molecular replacement with MOLREP (17) using the PDB entry 4BMA as the 
template (13). This gave a solution with two molecules in the asymmetric unit. The resulting electron density map 
was of good quality, allowing WarpNtrace (18) to build a model containing most residues. REFMAC (19) was 
used for further refinement, iterated with model building using COOT (20), producing a final models with the 
statistics shown in Table 1. Models for ligands were not included until their conformations were fully defined by 
unbiased |Fo|- |Fc|, calc electron density maps. Ligand structures and topologies were generated by PRODRG(21). 
WHATIF (22) was used to calculate hydrogen bonds and PyMOL was used to generate figures (23).
Enzyme kinetics and inhibition 
AfUAP1 steady-state kinetics was studied under linear conditions with not more than 10 % of the substrate 
converted to products. The activity of the enzyme in the forward direction was determined as described previously 
(13). The enzymes were used at 20 nM with the exception of K148M mutant that was used at 185 nM. The 
absorbance intensity data were analyzed with nonlinear regression analysis using GRAFIT 5 (24) with the default 
equations for the first-order reaction rates and Michaelis-Menten steady-state kinetics. To investigate AfUAP1 
inhibition by meUTP the forward reaction (formation of UDP-GlcNAc) was assayed using high performance 
anion exchange chromatography (HPAEC) based assay. The reaction mixtures (20 µM UTP, 50 µM GlcNAc-1P, 
1 mM DTT, 5 nM enzyme, 50 mM Tris-HCl pH 8.0, 10 mM MgCl2 and 2 % glycerol, total volume 100 µl) with 
and without varying concentrations of the inhibitor (0–1000 µM) were incubated for 30 min and the reactions 
were terminated by the addition of 10 µl of 0.1 M NaOH (~10 mM final concentration)  prior to analysis on a 
CarboPac-PA-1 column (Dionex) equilibrated with a 80:20 mixture of 1 mM NaOH  and a 1:1 mixture of 1 mM 
NaOH and 1 M sodium acetate as described previously (25). The eluent was monitored at 260 nm and peaks were 
identified by comparison to standards. The IC50 was calculated using Graphpad Prism software, CA, USA 
(www.graphpad.com).
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6Synthesis of an ,-methylenebisphosphonate UTP (meUTP) 
Compound 2 (Scheme 1): To a hot (60 °C) solution of 2´, 3´-O-isopropylidene uridine 1 (0.668 g, 2 mmol), 
triphenylphosphine (1.05 g, 4 mmol), and trimethyl methylenediphosphonate (26) (0.88 g, 4 mmol) in THF (10 
mL) diisopropylazodicarboxylate (1 mL, 5 mmol) was added dropwise. The reaction was further refluxed for 2 
h, cooled to RT and concentrated. The residue was purified by flash chromatography in DCM-MeOH 0 10 % 
to give 0.89 g (1.84 mmol, 92 %) of the target product as a mixture of two isomers on the -phosphorous atom.
 HRMS (positive) m/z 501.1478; expected for C17H31N2O11P2 [M+H]+ 501.1403.
1H NMR (500 MHz, CDCl3)  10.20 (2d, 1H), 7.43 (d, J = 2.8, 0.5H), 7.41 (d, J = 2.7, 0.5H), 5.73 (d, J = 2.3, 
0.5H), 5.69 (d, J = 2.3, 0.5H), 5.67 (d, J = 5.8, 0.5H), 5.65 (d, J = 5.8, 0.5H), 4.94 – 4.91 (m, 1H), 4.86 (dd, J = 
6.4, 3.7, 0.5H), 4.82 (dd, J = 6.5, 3.5, 0.5H), 4.34 – 4.22 (m, 3H), 3.76 – 3.74 (m, 4.5H), 3.73 – 3.72 (m, 4.5H), 
2.50 (dt, J = 21.2, 1.2, 2H), 1.49 (s, 3H), 1.27 (s, 3H).
13C NMR (126 MHz, CDCl3)  163.89, 150.36, 142.41, 142.33, 114.29, 102.49, 93.64, 93.30, 85.27, 85.22, 84.11, 
80.50, 80.41, 77.50, 65.88, 65.82, 65.77, 53.42, 53.33, 53.27, 53.21, 52.44, 52.39, 26.97, 25.13, 23.66 (dt, J = 
137.6, 8.2).
31P NMR (202 MHz, CDCl3)  21.81 (d, J = 6.4), 21.76 (d, J = 6.4), 21.70 (d, J = 6.4), 21.41 (d, J = 6.4).
Compound 3: A solution of 2 (0.48 g, 1 mmol) in DCM (10 mL) and aqueous 90 % trifluoroacetic acid (2 mL) 
was kept at RT for 1 h and concentrated. The residue was co-evaporated with toluene (22 mL). The final residue 
was purified by flash chromatography in DCM-MeOH 115 % to give 0.379 g (0.85 mmol, 85 %) of the 
intermediate diol. A solution of the above material (0.379 g, 0.85 mmol) in pyridine (5 mL) was treated with iso-
butyric anhydride (0.415 mL, 2.5 mmol) in the presence of 4-(dimethylamino) pyridine (0.012 g, 0.1 mmol) at 
RT for 5 h. The reaction was quenched with MeOH (0.5 mL), kept for 10 min and concentrated. The residue was 
dissolved in DCM and washed successively with 1 M HCl, water, and a mixture of NaHCO3 saturated solution 
and brine. The organic layer was dried and concentrated. The residue was purified by flash chromatography DCM-
MeOH 16 % to give 0.43 g (0.74 mmol; 87 %) of the target compound (two isomers on -phosphorous atom).
HRMS (positive) m/z 858.1673; expected for C21H35N2O13P2 585.1614 [M+H]+ 585.1614.
1H NMR (500 MHz, CDCl3)  10.10 (2d, 1H), 7.74 (d, J = 8.2, 0.5H), 7.67 (d, J = 8.2, 0.5H), 6.13 (dd, J = 6.6, 
1.3, 0.5H), 5.77 (dd, J = 8.1, 1.9, 0.5H), 5.73 (dd, J = 8.1, 1.9, 0.5H), 5.44 (dd, J = 5.9, 3.7, 0.5H), 5.37 (dd, J = 
5.9, 3.5, 0.5H), 5.30 (t, J = 6.2, 0.5H), 5.25 (t, J = 6.4, 0.5H), 4.45 – 4.41 (m, 0.5H), 4.39 – 4.32 (m, 1H), 4.24 – 
4.20 (m, 1H), 3.82 – 3.74 (m, 9H), 2.62 – 2.46 (m, 4H), 1.14 (bs, 3H), 1.13 (bs, 3H), 1.10 – 1.07 (m, 6H).
Page 33 of 60 RSC Chemical Biology
713C NMR (126 MHz, CDCl3)  175.79, 175.69, 175.51, 163.39, 163.36, 150.69, 150.65, 140.07, 139.99, 103.50, 
103.36, 86.13, 85.89, 81.21, 81.15, 81.04, 80.98, 77.37, 72.38, 72.31, 69.91, 69.87, 65.37, 65.34, 53.33 (m), 33.65, 
33.54, 23.93 (dt, J = 137.3, 14.2) 18.82, 18.71, 18.63.
31P NMR (202 MHz, CDCl3)  22.44 (d, J = 7.3), 21.87 (d, J = 6.6), 21.46 (d, J = 7.3), 21.41 (d, J = 6.7).
Compound 4: To a solution of 3 (0.06 g, 0.1 mmol) in acetonitrile (1 mL) bromotrimethylsilane (0.13 mL, 1 
mmol) was added at RT and the reaction was kept for 2 h. The reaction was concentrated and the residue was co-
evaporated with aqueous MeOH (10:1) (1 mL). The residue was co-evaporated with toluene (21 mL) to remove 
traces of water. The residue was dissolved in anhydrous MeOH (1 mL) and treated with a 25 % stock solution of 
NaOMe (0.05 mL) at room temperature (RT) for 3 h. The reaction was quenched with Dowex50W8-Et3NH+. The 
resin was filtered off and the filtrate was concentrated. The residue was dissolved in water and freeze-dried to 
give 0.072 g (0.1 mmol) of the target compound as a fluffy white solid.
HRMS (negative) m/z 401.0149; expected for C10H15N2O11P2 [M-H]- 401.0151
1H NMR (500 MHz, MeOD)  7.76 (d, J = 8.1, 1H), 5.73 (d, J = 4.6, 1H), 5.71 (d, J = 8.1, 1H), 4.14 (dt, J = 9.8, 
5.2, 2H), 4.05 – 4.00 (m, 1H), 3.98 – 3.87 (m, 2H), 2.96 (q, J = 7.3, 12H), 1.97 (dd, J = 27.1, 11.5, 2H), 1.03 (t, J 
= 7.3, 18H).
13C NMR (126 MHz, MeOD)  166.20, 151.74, 141.81, 102.46, 88.37, 83.31 (d, J = 7.6), 73.69, 69.54, 63.28 (d, 
J = 4.3), 46.57, 27.19 (t, J = 125.0), 8.
31P NMR (202 MHz, MeOD)  16.43, 14.2.
Compound 5: To a solution of 4 (0.072 g, 0.1 mmol) in DMF (1.5 mL) was added N, N´-carbonyldiimidazole 
(0.057 g, 0.35 mmol) and the mixture was stirred for 3 h at RT. The reaction was quenched by addition of MeOH 
(0.01 mL) and concentrated. The residue was co-evaporated with DMF (2×1mL) and dissolved in a fresh portion 
of DMF (1 mL). A 0.5 M solution of tributylammonium phosphate in DMF (1 mL) was added to the above 
solution at RT, which resulted in immediate formation of white precipitate. The reaction was further stirred at RT  
for 16 h. The reaction was diluted with water (2 mL) and concentrated. The residue was dissolved in water and 
purified by ion-exchange chromatography using Fast Flow Sepharose Q (15×200 column); linear gradient 
NH4HCO3 0.04 to 0.4 M, flow-rate 5 mL/min; detection on 214 and 254 nm. The appropriate fractions were 
pooled and freeze-dried to give 0.0085 g (0.015 mmol, 15 %) of the target compound as white fluffy substance.
HRMS (negative) m/z 480.9857; expected for C10H16N2O14P3 [M-H]- 480.9814.
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81H NMR (500 MHz, D2O)  7.89 (d, J = 8.1, 1H), 5.85 – 5.81 (m, 2H), 4.29 – 4.25 (m, 2H), 4.13 (d, J = 1.9, 1H), 
4.10 – 4.01 (m, 2H), 2.29 – 2.18 (dt, J = 21, 2, 2H).
31P NMR (202 MHz, D2O)  17.80 (d, J = 9.3), 6.18 (dd, J = 23.6, 9.3), -9.25 (d, J = 23.6).
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9RESULTS AND DISCUSSION
AfUAP1 undergoes large conformational changes during catalysis
To explore UAP1 catalytic mechanism and provide a structural framework for the design and optimization of 
inhibitors, crystal structures of AfUAP1 in complex with substrates/products were determined. Initially, a high-
resolution dataset of a Michaelis complex of the enzyme at 1.75 Å was trapped using crystals grown in the 
presence of UDP-GlcNAc and subsequently soaked with PPi and Mg2+ (Table 1 and Figure 2; RMSD of 1.6 Å 
on C atoms compared to the “apo-like” structure described earlier with PDB 4BMA (13)). One of the two protein 
molecules in the asymmetric unit showed an empty active site, and is considered here as the “apo-like” form 
(Figure 2). To understand the catalytic mechanism, two further complexes were also determined – a substrate 
complex with GlcNAc-1P and a substrate complex with UTP (Table 1 & Figure 2).
   The overall structure of AfUAP1 is similar to that previously described for eukaryotic UAP1s CaUAP1(11) and 
HsUAP1(12) ( Figures 3A and 3B). AfUAP1 and CaUAP1 share 52% sequence identity (Figure S1) and 
superposition of the overall structures of these two proteins reveals an RMSD of 1.1 Å (on all C atoms), 
indicating a similar overall structure. AfUAP1 possesses a three-domain fold with the central catalytic domain 
flanked by two domains of unknown function (Figure 2A). While the N-terminal domain of AfUAP1 consists 
entirely of four -helices (Figure 2A), the central domain consists of seventeen -strands and twelve helices 
adopting the Rossmann fold. The C-terminal domain consists of four short -strands and a long helix that connects 
to the central domain (Figure 2A).  AfUAP1 has a large active site cleft, with its wall being formed by the central 
domain and the C-terminal domains (Figure 2). Ligand binding at the bottom of the active site induces a number 
of significant conformational changes compared to the “apo-like” structure. The binding of GlcNAc-1P to 
AfUAP1 is stabilized by hydrogen bonds with Asn249, Gly316, Tyr330, Glu329, Asn355 and Lys437. 
Interestingly,  a PO43- molecule which occupies the same position as the UTP -phosphate interacts with R141 
and T140 (Figures 2B, 2C and 4) and induce a shift of loops A, B, C, D and * on the central domain, closing the 
active site (Figures 2A and 2B) (RMSD vs. “apo-like” structure = 2.1 Å on all C atoms). Similar interactions 
were seen in the CaUAP1-GlcNAc-1P complex with equivalent residues (Tyr310, Asn227, Glu309, Gly294, 
Asn335, and Lys421) except for the absence of the PO43- molecule, which prevents the ordering of R116 (R141 
in AfUAP1)(Figures 3C and 3D) (11). We hypothesise that in the absence of this PO43-  molecule, the binding of 
GlcNAc-1P alone would only cause partial closure of the active site. In contrast, UTP appears to bind AfUAP1 
with no significant conformational changes (RMSD vs. “apo-like” structure = 1.1 Å on all C atoms), interacting 
with Gly136, Gln138, Gly139, Thr140, Lys148, Arg141, Gln222, Gly248, Cys277 and Lys383 (Figures 2B, 2C 
and 4). However, binding of UDP-GlcNAc, magnesium and PPi to the enzyme causes a considerable change to 
the overall structure of the protein (Figures 2B, 2C and 3) (RMSD vs. “apo-like” structure = 2.1 Å on all C 
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atoms). UDP-GlcNAc binds to the enzyme with the GlcNAc and uridine moieties of the molecule occupying 
positions equivalent to GlcNAc-1P (max. atomic positional shift = 0.6 Å) and UTP (max. atomic positional shift 
= 1.0 Å), also establishing similar hydrogen bonding interactions (Figures 2B, 2C and 4). Further hydrogen bonds 
are established between  and  phosphates of UDP-GlcNAc and Arg141 and Lys437 (Figure 4). The PPi 
molecule occupies a position approximately equivalent to the  and -phosphates of UTP (max. positional shift 
on phosphorus atoms = 1.5 Å), and is tethered by interactions with positively charged residues, such as Arg141, 
Lys437 and Lys148 (Figure 4). A comparison of AfUAP1-UDP-GlcNAc-Mg+2-PPi and CaUAP1-UDP-GlcNAc 
complexes reveals that UDP-GlcNAc occupies the same position and makes identical interactions with equivalent 
residues in both enzymes (Figures 3C and 3D) (11). Interestingly a SO42- ion occupies the same position as one 
of the phosphates of the PPi seen in the AfUAP1-UDP-GlcNAc-PPi-Mg2+ complex (Figures 4 and 3D). Taken 
together, it appears that to accommodate substrates and release products, AfUAP1 undergoes large conformational 
changes during catalysis. 
The Mg2+ ion aligns the reactants for catalysis
Several reports have shown that UAP1 requires divalent cations, such as Mg2+, for full activity (7, 11, 12). The 
UDP-GlcNAc-PPi-Mg2+ Michaelis complex of the reverse reaction trapped here reveals the key role the metal 
plays in coordinating the reactants/products (Figures 4 and 5). The magnesium ion with an occupancy of 1.0, is 
pentacoordinated by the phosphate groups of pyrophosphate, UDP-GlcNAc and two water molecules in a 
tetragonal bipyramidal arrangement (distances ranging between 2.0 and 2.4 Å) while the 6th ligand is absent 
(presumably a disordered water molecule), providing the necessary geometry to place the attacking oxygen of 
pyrophosphate within 2.2 Å distance (angle of attack 166o) from the UDP-GlcNAc -phosphate (Figure 5A), 
compatible with a direct displacement mechanism (Figure 4). Interestingly, the high-resolution electron density 
map also reveals an alternative conformation for the UDP-GlcNAc -phosphate that flips 1.7 Å resulting in an 
“off conformation”, and placed 3.5 Å from the PPi oxyanion (Figures 4 and 5). It is possible that this “off 
conformation” resembles the product of the forward synthesis preceding a conformation that is the Michaelis 
complex of the reverse pyrophosphorolysis reaction. Interestingly, superposition of two separate CaUAP1-UDP-
GlcNAc complexes (pdb entries 2yqs and 2yqj (11)) reveals a similar dual conformation as observed in  the 
AfUAP1-UDP-GlcNAc-PPi-Mg2+ complex described here (Figure 3E and 3F). The role of the metal is firstly to 
correctly align the UTP with  GlcNAc-1P, and UDP-GlcNAc with PPi, and secondly, to facilitate close proximity 
of the negatively charged phosphate groups. Similarly, Pelissier et al. (27) also proposed that Mg2+ prevents 
electrostatic repulsion between phosphate groups of the substrates Man-1P and GTP of the thermophilic 
bacterium Thermotoga maritima pyrophosphorylase. Thus, the Mg2+ ion aligns the reactants for catalysis.
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A conserved lysine occupies the position of a second metal ion in GlmU
The structure suggests that the reverse (pyrophosphorolysis) reaction may be facilitated by an increase in 
electrophilicity of the -phosphorus induced by a salt bridge interaction between a lysine that is conserved in 
eukaryotes (Lys437 in AfUAP1, Figure S1) and the  phosphate of UDP-GlcNAc (Figure 5). Similarly, Lys437 
may facilitate the forward reaction by inducing an increase of the electrophilic character of the UTP -phosphorus 
(Figure 5). 
   Recently the structures of a ternary complex of a bacterial UAP from M. tuberculosis named MtGlmU, and 
other classes of nucleotidyltransferases (28, 29), revealed an unusual catalytic mechanism dependent on two-
metal-ions (30) (Figures 4 and 5B). GlmUs are bacterial enzymes with two domains catalysing two independent 
reactions. While the C-terminal domain catalyses an acetyltransfer reaction from acetyl-CoA to glucosamine-1P 
(GlcN-1P) to form N-acetylglucosamine-1P (GlcNAc-1P), the N-terminal domain possesses uridylation activity 
converting GlcNAc-1P to UDP-GlcNAc in the presence of UTP (30). In the MtGlmU structure, UDP-GlcNAc 
and PPi interact through hydrogen bonds with Ala14, Gly17, Thr18, Gln83, Gly88, Thr89, Gly151, Glu166 and 
Asn181, and salt bridges with Lys26 and Arg19 (Figure 4). The magnesium atom in both the AfUAP1 and 
MtGlmU ternary complexes occupy similar positions but they differ in how they are coordinated (Figure 5). The 
metal ion in AfUAP1 is pentacoordinated, whereas the magnesium atom in GlmU is hexacoordinated by the 
phosphate groups of PPi and UDP-GlcNAc, and three water molecules (Figure 5). The average bond angle of 
coordination of magnesium in the AfUAP1_UDP-GlcNAc-PPi_Mg2+ complex is 89  10o while in the MtGlmU-
UDP-GlcNAc-PPi-Mg2+-Co2+ complex it is 90  17o. A comparison of the angles of magnesium coordination in 
AfUAP1 and MtGlmU complexes is shown in Table 2.  With respect to the reaction mechanism, the pyrophosphate 
is within 2.8 Å (with an angle of attack of 169o) from the UDP-GlcNAc -phosphate and therefore at a distance 
not as optimal as that found in the Michaelis complex of AfUAP1, suggesting that a positional shift of 
UDP-GlcNAc -phosphate might be required in order to facilitate catalysis (Figure 5A). 
  Interestingly, the crystal structure reveals the presence of a second metal in the MtGlmU identified as cobalt, 
although experiments in solution confirm that GlmU requires two magnesium ions for catalysis (30). Furthermore, 
this second metal binding site is found in a position occupied by Lys437 in AfUAP1 (Figures 4 and 5B). In the C. 
albicans UAP1 crystal structure, Lys421 occupies a similar position and was also predicted to play the role of the 
second metal ion (11).  In Leishmania major UDP-glucose pyrophosphorylase (31) and a bacterial GDP-mannose 
pyrophosphorylase (27), a lysine was also observed to occupy the position of the second Mg2+ seen in C. 
glutamicum UGP (29).  It is possible that bacterial GlmUs and eukaryotic UAP1s follow a similar catalytic 
mechanism but differ in the number of metal atoms and consequently in how the electrophilic character of -
phosphorous is enhanced. In eukaryotes a single magnesium atom is essential for the reaction while the position 
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of the second magnesium atom present in bacteria is occupied by a basic amino acid. Thus, a conserved lysine in 
AfUAP1 occupies the position of a second metal ion in GlmU.
 
Lys437 is required for AfUAP1 catalysis
Several of the amino acid residues (e.g. equivalents of Thr140, Arg141 and Lys148 in AfUAP1, Figure 4) shown 
to bind the phosphates of nucleotides/phosphosugars in complexes with other UAP1 enzymes have been mutated 
previously and shown to be important for substrate binding/catalysis (7). However, to probe the role of Lys437 
in catalysis, we carried out site-directed mutagenesis of this basic residue and two other amino acids involved in 
stabilization of substrates/products (7, 11, 12). The mutants have the same expression levels as the wild type 
enzyme as confirmed by SDS-PAGE  (Figure S2A). As mentioned earlier, Lys437 makes direct contacts with the 
phosphate group of GlcNAc-1P (Figure 4) and with the  and -phosphate of UDP-GlcNAc (Figure 4). Tyr330 
establishes a hydrogen bond with the phosphate group of GlcNAc-1P, and Lys148 is involved in UTP binding, 
contacting the phosphate groups of UTP and pyrophosphate (Figure 4) through direct and indirect hydrogen 
bonds. In agreement with the structural data, the K148M and Y330F mutants affect the Km values of UTP (10-
fold increase) and GlcNAc-1P (6-fold increase), respectively (Table 3). The K437A mutant shows an increase in 
the Km values of both substrates (32 and 10-fold increase in the Kms of GlcNAc-1P and UTP respectively), which 
may be the result of disrupting the interaction of Lys437 with the phosphate groups of GlcNAc-1P and UDP-
GlcNAc (Figure 4). To probe the effect of this residue further we made  K437R and K437M mutants. The K437R  
mutant shows a slight increase in Km by 5- and 4-fold for GlcNAc-1P and UTP, respectively while the K437M 
mutant completely abolishes enzyme activity (Table 3 and Figure S2B). The increase in activity by the K437R 
mutant compared to the K437A could be as a result of the arginine mimicking the positive charge present on 
Lys437, which is essential for an optimal catalytic efficiency. However, the activity of K437R is 2.9-fold lower 
than the wild type enzyme likely due to the bulkier arginine side chain not being positioned optimally with respect 
to the -phosphate group of either UTP or UDP-GlcNAc. Overall, all the four mutants reduce kcat (Table 3). Out 
of the five mutants tested, K437A has the largest effect on catalytic efficiencies with a 433 and 117-fold reduction 
towards GlcNAc-1P and UTP, respectively (Table 3) and K437M completely inactivates the enzyme. Therefore, 
our data suggest that these residues play key roles in aligning the substrates for UAP1-catalyzed UDP-GlcNAc 
synthesis/pyrophosphorolysis, in particular supporting the role of Lys437 as being essential for catalysis in line 
with the proposed catalytic mechanism (Figure 5C). 
Design and synthesis of meUTP as a mechanism-inspired inhibitor 
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We attempted to use the AfUAP1 structural/mechanistic insights generated here to design a mechanism-inspired 
substrate analogue inhibitor. The AfUAP1-UDP-GlcNAc-PPi Michaelis complex (Figure 4) and the proposed 
reaction mechanism (Figure 5) reveal the direct attack of the phosphate group of GlcNAc-1P on UTP , -
phosphodiester bond leading to the formation of the products UDP-GlcNAc and PPi. This suggests that an ,-
methylenebisphosphonate analogue of UTP (meUTP)  in which the scissile , -pyrophosphate bond is replaced 
with a methylenebisphosphonate could inhibit this forward reaction (Figure 6A). Synthesis of this analogue was 
initiated with the preparation of a fully protected UDP methylenebisphosphonate analogue 2 (Scheme 1) using a 
variant of Mitsunobu esterification of 2, 3-O-isopropylideneuridine with methylenebisphosphonic acid 
trimethylester as a key step (Scheme 1) (26). In these conditions, the target compound was obtained in 90% yield 
on a gram scale after conventional chromatography. This novel and highly effective method offers valuable 
advantages over the reported procedure for direct synthesis of nucleoside 5-methylenebisphosphonates, which 
requires large excess of methylenebisphosphonic acid tetrachloride (32) to be used to minimize formation of 
symmetrical and/or cyclic by-products. According to the initial synthetic plan, compound 2 was converted into 
the 2, 3-di-O-isobutyrate derivative 3 in a two-step protective group exchange (Scheme 1). Unfortunately, all 
attempts to perform selective mono demethylation at the terminal phosphorous atom of the methylene 
bisphosphonate moiety in 3 to ensure regioselective formation of the triphosphate bond were unsuccessful. After 
some experimentation, conventional phosphorylation of the fully deprotected , - methylenebisphosphonate 
UDP analogue 4 was proven to be the easiest way to reach the target molecule. To this end, stepwise removal of 
the protecting groups from 3 gave rise to 4 in near quantitative yield. Finally, phosphorylation of 4 with N, N´-
carbonyldiimidazole and tributylammonium phosphate in DMF for 16 h furnished the desired compound 5 or  
meUTP (Figure 6A) in a modest 15 % yield after ion-exchange chromatography. The structure of compound 5 
was ultimately confirmed by 31P NMR, with the spectrum showing the characteristic pattern of three different 
phosphorous signals as doublet at  17.8 (J = 9.3), doublet of doublets at  6.18 (J = 23.6, 9.3), and doublet at  -
9.25 (J = 23.6) corresponding to   , and  phosphorous atoms only compatible with the linear phosphate-
methylenebisphosphonate structural motif. The HPLC profile of the purified compound 5 (Figure S3A) reveals 
the content of the main substance no less than 98% along with a contamination (2%) corresponding to meUDP.
   Initial experiments showed that AfUAP1 was unable to utilize the meUTP as substrate. Therefore, potential 
inhibition by this compound was studied by an HPAEC assay, allowing us to follow the conversion of UTP to 
UDP-GlcNAc. Using this approach, it was observed that at increasing concentrations of the meUTP, less UTP is 
consumed while the amount of UDP-GlcNAc produced decreases, suggesting that meUTP is an AfUAP1 inhibitor 
(Figure 6B). We have noted that while the concentration of the inhibitor increases, a peak at Rt = 3.33 min 
corresponding to meUDP impurity also increases steadily. At 200 µmol concentration of the inhibitor the 
estimated concentration of meUDP reaches about 10-15 µmol, which was deduced from the comparison of the 
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areas under the meUDP, UDP-GlcNAc, and UTP peaks. This estimation exceeds the calculated concentration of 
meUDP impurity based on 2% contamination of the meUTP 2 to 3 folds. It is not clear if this is a result of 
enzymatic conversion of meUTP or whether the meUDP level increases due to partial hydrolysis of the inhibitor 
in mildly basic conditions of the reaction quench/sample processing. Additionally, a peak at Rt = 3.80 min was 
identified as UDP and probably originates from the similar decay of UTP during processing of the enzymatic 
reaction. To rule out whether meUDP is the source of the observed enzyme inhibition, we showed that AfUAP1 
is not inhibited by  500 µM meUDP (Figures S3B and C), eliminating this possibility. 
   The data show that the  -methylenebisphosphonate UTP analogue 5 (meUTP) inhibits AfUAP1 activity with 
an IC50 of 115 ± 40 M (Figure 6C), representing one of the few examples of a rationally designed inhibitor of 
this class of enzyme. Although this compound is likely to be an aspecific inhibitor of UAP1s and other UTP-
dependent enzymes, further structural modifications guided by small differences between the human and the 
fungal enzymes (13) may lead to development of selective inhibitors of  fungal UAP1. The possibility of inhibition 
of specific UAP1s, despite high sequence conservation in this family, has recently been demonstrated with a 
selective UTP-competitive inhibitor of T. brucei UAP1 (TbUAP1) (10). This inhibitor was shown to compete 
with UTP, binding with a KD of 9.3 µM (IC50 of 37 ± 4 µM), making it more potent than the meUTP (10). In 
addition, the TbUAP1 inhibitor was selective towards this parasite enzyme because it binds to a unique allosteric 
site on TbUAP1 that is not present in either the human or the fungal UAP1. 
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CONCLUDING REMARKS
The structural data described here provide detailed snapshots of the enzyme in complex with substrates/products, 
revealing for the first time the key role that the magnesium ion plays in stabilizing the Michaelis complex of 
pyrophosphorolysis, aligning the reactants for a direct attack by the pyrophosphate group, in parallel with 
significant conformational changes in the enzyme. We also show that eukaryotic UAP1s depend solely on one 
magnesium ion unlike the bacterial GlmUs that require two magnesium ions for catalysis. Conserved amino acids 
interacting with the negative charges on the phosphates were shown to be important for full catalytic activity and 
in particular we demonstrated that eukaryotic UAP1s use a conserved lysine (Lys437 in AfUAP1) as a key electron 
withdrawer to increase the electrophilic character of the -phosphorous of either UTP or UDP-GlcNAc in order 
to promote the forward or reverse catalytic reaction respectively. Furthermore, we have reported for the first time 
that an ,-methylenebisphosphonate UTP analogue (meUTP) inhibits AfUAP1 with an IC50 of 115 M. This 
and its derivatives may also be a useful reagent for the study of the broader family of sugar nucleotide 
pyrophosphorylases. For example, it could be used in kinetic protein crystallography experiments that could help 
to trap kinetic states of pyrophosphorylases, and to determine the outcome of inhibiting these enzymes in 
appropriate cell models. Together, the novel mechanistic insights and the substrate-based inhibitor reported here 
will aid the future exploitation of this genetically validated enzyme as a potential target for the discovery of novel 
antifungal compounds. 
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FIGURE LEGENDS
Figure   1: UDP-GlcNAc biosynthetic pathway. The four main enzymes of the pathway are coloured in red. 
Metabolites feeding the pathway are in blue and the final product of the pathway is coloured in pink. The various 
fates of UDP-GlcNAc are linked by the branching arrows.
Figure 2: Ligand-induced conformational changes of AfUAP1. (A) Cartoon representation of AfUAP1, the N-
terminal domain is coloured red, the C-terminal domain is coloured blue and the pyrophosphorylase domain is 
coloured in grey. Loops A, B, and C-D together with * are coloured in yellow, cyan and pink, respectively. The 
flexible regions are indicated by red arrows. (B) Cartoon representation of the superposed “apo-like” structure 
with the different complexes showing a large area around the active site. While the colours for the mobile regions 
are maintained for the “apo-like” structure, the same loops and * are coloured in orange in the different 
complexes. (C) The surface representation shows conformational changes around the active site in the various 
AfUAP1 complexes. The substrates and the products are shown as sticks, the Mg2+ ion is shown as a blue sphere. 
Figure 3: Comparison of AfUAP1 with other UAP1s. (A). Overall structure of CaUAP1. Coloured in orange, 
cyan and purple are the N-terminal, catalytic and C-terminal domains, respectively. (B) Overall structure of 
HsUAP1. Coloured in red, green and blue are the N-terminal, catalytic and C-terminal domains, respectively. (C) 
Active site of CaUAP1with GlcNAc-1P bound. Active site residues are shown in sticks. Hydrogen bond 
interactions are shown as black dashes. (D) Active site of CaUAP1with UDP-GlcNAc-SO42- bound. Active site 
residues are shown in sticks. Hydrogen bond interactions are shown as black dashes. SO42- is shown as sticks. (E) 
Stick representation of UDP-GlcNAc in the AfUAP1-UDP-GlcNAc-PPi-Mg2+ ternary complex, showing the 
observed dual conformation around the -phosphate. (F) Superposition of UDP-GlcNAc from the CaUAP1-
UDP-GlcNAc product complex (pdb: 2yqs, blue) with UDP-GlcNAc from the CaUAP1-UDP-GlcNAc reaction-
completed product complex (pdb: 2yqj, green). This superposition recapitulates the dual conformation observed 
in the AfUAP1-UDP-GlcNAc-PPi-Mg2+ complex.
Figure 4:  Active site of  AfUAP1 complexes and comparison with the MtGlmU ternary complex. Amino 
acids and ligands are shown as sticks with grey and green carbon atoms respectively. Water molecules, Mg2+ and 
Co2+ atoms are shown as spheres in red, blue and pink respectively. Hydrogen bonds and metal coordination are 
represented with dotted lines coloured black and orange respectively. The unbiased |Fo |-|Fc | calc electron density 
maps for the ligands is shown in blue, contoured from 2.2 to 2.5 depending on the ligand. The blue characters 
indicate the residues mutated in the mutagenesis assay.
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Figure 5: Magnesium coordination and AfUAP1 mechanism. (A) Magnesium coordination in the AfUAP1-
UDP-GlcNAc-PPi-Mg2+ complex active site. A view of the active site of the AfUAP1-UDP-GlcNAc-PPi–Mg2+ 
and MtGlmU-UDP-GlcNAc-PPi–Mg2+-Co2+complexes. The attack distance for pyrophosphorolysis is 2.2 and 2.8 
Å and the attack angle is 166o and 169o for UAP1 and GlmU, respectively. The distance between the -phosphates 
in both UDP-GlcNAc adopting the dual conformation is 1.7 Å. The Mg2+ is tetragonal bipyramidally coordinated 
(albeit with a disordered 6th ligand in AfUAP1) as suggested by coordination distances and angles. (B). 
Magnesium coordination in the MtGlmU-UDP-GlcNAc-PPi–Mg2+-Co2+ complex active site. (C) Schematic 
diagram of the proposed forward and reverse reaction mechanisms. The left panel indicates chemical bond 
formation/cleavage (cyan arrows) in the AfUAP1-PPi-UDP-GlcNAc ternary complex shown in Fig. 5A leading 
to the formation of GlcNAc-1P and UTP.  The right panel using the same ternary complex structure as a template 
indicates chemical bond formation/cleavage in the reverse reaction leading to the formation of UDP-GlcNAc and 
PPi from GlcNAc-1P and UTP is proposed.
Figure 6: Kinetic characterization of meUTP (compound 5). (A) Chemical structures of UTP and  meUTP. 
The α, β-methylenebisphosphanate is indicated in red.  (B) HPAEC chromatogram of AfUAP1 inhibition 
by  meUTP, where [UTP] ≈ Km and [GlcNAc-1-P] is in excess. The inhibitor concentration is indicated on each 
curve (0 - 200 µM). The reaction mixtures (20 µM UTP, 50 µM GlcNAc-1P, 1 mM DTT, 5 nM enzyme, 50 mM 
Tris-HCl pH 8.0, 10 mM MgCl2 and 2 % glycerol, total volume 100 µl) with and without varying concentrations 
of the inhibitor  were incubated for 30 min and the reactions were terminated by the addition of 10 µl of 0.1 M 
NaOH(~10 mM final concentration)  prior to analysis on a CarboPac-PA-1 column (Dionex) equilibrated with a 
80:20 mixture of 1 mM NaOH  and a 1:1 mixture of 1 mM NaOH and 1 M sodium acetate. The eluent was 
monitored at 260 nm and peaks were identified by comparison to standards. (C) IC50 curves of  meUTP with fixed 
[UTP] and [GlcNAc-1P] and varying concentration of inhibitor.
Figure S1: Multiple sequence alignment of UAP1s with MtGlmU. Multiple sequence alignment of AfUAP1, 
the human AGX1 and AGX2 isoforms, C. albicans UAP1 (CaUAP1) and MtGlmU. Secondary structure elements 
from the AfUAP1 structure are shown with -helices and -strands in red. The key highly conserved lysine in 
eukaryotes (Lys437 in AfUAP1) is highlighted in cyan and indicated with a green inverted triangle. The insertion 
loop is underlined and AfUAP1 loops are indicated with a line and labelled appropriately as well as helix *.
Figure S2: Role of K437 in catalysis. (A) SDS-PAGE of all mutants. 1. WT, 2. K437A, 3. Y330F, 4. K148M, 
5. K437R. All proteins were overexpressed and in the soluble fraction. (B) Activity of K437A,  K437R and 
K437M compared to the wild type. Experiment was done in triplicates and result expressed as mean  SEM. The 
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Biomol Green assay was performed as described in the Materials and Methods using equal enzyme concentration 
of 20 nM enzyme, 300 µM UTP and 250 µM GlcNAc-1P terminating after 20 min. 
Figure S3: (A). HPLC chromatogram of meUTP. The major component (meUTP) has a retention time of 6.94. 
The residual peak of meUDP has a retention time of 3.56 min. The major compound comprises 98% of the 
mixture. (B).  AfUAP1 activity in the absence of meUDP. To investigate the effect of meUDP an HPLC assay 
was performed (Waters Xselect 150 × 4.6 mm column, flow rate 1 mL/ min. Buffer A 100 mM phosphate 
/ 2.5 mM Bu4HSO4 in water; Buffer B 100 mM phosphate/ 2.5 mM Bu4HSO4 in water-MeCN 1:1). The 
assay was performed using 5 nM enzyme, 25 µM UTP and 50 µM GlcNAc-1P, for 10 min. The 
chromatogram shows the production of UDP-GlcNAc (Rt = 4.5 min). It also shows a peak 
corresponding to UDP (Rt = 5.55 min) which is thought to be a result of gradual hydrolysis of UTP. The 
remaining UTP elutes at Rt = 9.5 min. (C). Effect of meUDP on AfUAP1 activity. The experiment was 
done as described for B in the presence of 500 µM meUDP. The chromatogram shows meUDP elutes at 
Rt = 3.56 min; concentration far above the scale. Production of UDP-GlcNAc (Rt = 4.5 min) remains 
unaffected. It also shows a peak corresponding to UDP (Rt = 5.55 min) which is taken to be a result of 
gradual hydrolysis of UTP. The remaining UTP elutes at Rt = 9.44 min. 















































































Scheme 1: Synthesis of α,β-methylenebisphosphanate UTP analogue (meUTP). Reagents and 
conditions: i) DIAD, PPh3, trimethyl methylenediphosphonate, THF, 2 h, reflux, 92%; ii) (a) TFA-H2O 
(9:1), DCM, 2 h, RT, 85%, (b) (i-PrCO)2O, Py, DMAP, 5 h, RT, 87%; iii) (a) TMSBr, MeCN, 1 h, RT, (b) 
MeOH, MeONa, then Dowex50W8-Et3NH+, quant; iv) Im2CO, DMF, then (Bu3NH)3PO4, 16 h RT, ion-
exchange chromatography, 15%. 
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Resolution (Å) 20.0 (1.81 - 1.75) 20.0 (2.36 - 2.28) 20.0 (2.49 - 2.40)
Space group P212121 P212121 P212121
Unit cell
a (Å) 55.2 55.7 55.6
b (Å) 139.8 138.1 140.0
c (Å) 144.6 145.1 146.3
 =  =  () 90 90 90
No. of reflections 441409 157074 177172
No. of unique 
reflections
113044 49491 46020
I/ (I) 16.4 (2.4) 11.2 (2.4) 13.7 (3.2)
Completeness (%) 99.1 95.5 99.2
Redundancy 3.9 (3.8) 3.2 (3.0) 3.8 (3.0)
Rmerge (%) 5.8 (56.8) 11.6 (39.2) 8.6 (32.5)
RMSD from ideal 
geometry
Bond distance (Å) 0.008 0.009 0.010
Bond angle () 1.08 1.0 1.23
Rwork (%) 21.0 20.6 22.7
Rfree (%) 24.0 25.9 27.7
No. of residues 925 905 928
No. of water mol. 559 231 120
B-factors (Å2)
Overall 23.8 48.6 34.8
Protein 23.4 48.8 34.8









Values in parenthesis are for the highest resolution shell. All measured data were included in the refinement.
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 Table 2: Measurements of angles between Mg2+ and ligands in the AfUAP1-UDP-GlcNAc-PPi-Mg2+ 
and MtGlmu-UDP-GlcNAc-PPi-Mg2+-Co2+  complexes
AfUAP1-UDP-GlcNAc-PPi-Mg2+ MtGlmu-UDP-GlcNAc-PPi-Mg2+-Co2+
Atoms Angle (o) Atoms Angle (o)
W1Mg2+W2 100.1 W1Mg2+W2 80.7
W1Mg2+W3 nd W1Mg2+W3 103.3
W1Mg2+OBH 87.9 W1Mg2+O1A 88.7
W1Mg2+OAB 105.2 W1Mg2+O1 107.9
W3Mg2+OAA nd W3Mg2+O5 69.6
W3Mg2+W2 nd W3Mg2+W2 69.7
OAAMg2+OAB 79.7 O5Mg2+O1 80.0
OABMg2+OBH 82.8 O1Mg2+O1A 93.9
W3Mg2+OAB nd W3Mg2+O1 116.1
W2Mg2+OAA 76.0 W2Mg2+O5 92.1
W2Mg2+OBH 85.0 W2Mg2+O1A 76.4
OAAMg2+OBH 96.1 O1AMg2+O5 94.2
W1 = water 1, W2 = water 2 and W3 = water3 as indicated in the Figure 5. nd= not detectable due to 
absence of W3 in the AfUAP1 structure.
Table 3: Kinetic parameters of the forward reaction for the wild type and mutant forms of AfUAP1. The results 










WT 34  3 21  2 0.044  0.001 2.2  0.3 0.065 0.10
K148M 44  13 200  31 0.0074  0.0007 0.4  0.01 0.0091 0.002
Y330F 200  72 25  5 0.016  0.001 0.8  0.1 0.004 0.032
K437A 1100  900 200  62 0.0033  0.0004 0.17  0.02 0.00015 0.00085
K437R 155  29 88  12 0.027  0.003 1.3  0.1 0.008 0.015
K437M nd nd nd nd nd nd
Nd: not detectable.
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